Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.
Sponsor: Kuros Biosurgery AG
Summary
This is a phase IV post-marketing study for MagnetOs Putty and MagnetOs Easypack Putty. MagnetOs is a synthetic bone graft extender product that is routinely used by surgeon as treatment for hindfoot and ankle disorders. In this study, MagnetOs Putty and MagnetOs Easypack Putty will be use according to the latest Instructions For Use, standalone in the foot and ankle.
Official title: A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
126
Start Date
2025-11-25
Completion Date
2028-12
Last Updated
2026-04-09
Healthy Volunteers
No
Conditions
Interventions
MagnetOs
MagnetOs will be used at a volume of approximately 1-5 cc's for the TN, CC and ST joints, and up to 10 cc's for the tibiotalar joint.
Autograft
In this study, the comparator is autograft and will be used at a volume of approximately 1-5 cc's for the TN, CC and ST joints, and up to 10 cc's for the tibiotalar joint.
Locations (5)
Steadman Philippon Research Institute
Vail, Colorado, United States
Hughston Foundation Inc
Columbus, Georgia, United States
OrthoCarolina Research Institute, Inc
Charlotte, North Carolina, United States
Reconstructive Orthopaedic Associates II dba Rothman Orthopaedic Institute
Philadelphia, Pennsylvania, United States
Erlanger Orthopaedics
Chattanooga, Tennessee, United States